Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 32.02% is 14% below its 5-year average of 37.18%, near the high end of its 5-year range (2.40%–39.34%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.08% below its 12-month average of 33.38%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 32.02%.
DEBT TO ASSETS RATIO
32.02%
DEBT TO ASSETS RATIO AVG TTM
33.38%
DEBT TO ASSETS RATIO AVG 3Y
36.77%
DEBT TO ASSETS RATIO AVG 5Y
37.18%
DEBT TO ASSETS RATIO AVG 10Y
17.86%
DEBT TO ASSETS RATIO AVG 15Y
12.01%
DEBT TO ASSETS RATIO AVG 20Y
1.00%
CURRENT VS TTM AVG
-4.08%
CURRENT VS 3Y AVG
-12.92%
CURRENT VS 5Y AVG
-13.87%
CURRENT VS 10Y AVG
+79.25%
CURRENT VS 15Y AVG
+166.69%
CURRENT VS 20Y AVG
+3092.80%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+31919.11%
vs the sector median at left
ICU Medical, Inc.
Market Cap
$3.98B
Debt to Assets Ratio
32.02%
TTM Avg
33.38%
3Y Avg
36.77%
5Y Avg
37.18%
Market Cap
$4.14B
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.15B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.30B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.61B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.36B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.98B | 32.02% | 33.38% | 36.77% | 37.18% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.14B | 0.10% | N/A | N/A | N/A |
| Relay Therapeutics, Inc. (RLAY)vs › | $4.15B | 0.03% | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.16B | 0.13% | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.30B | 0.08% | N/A | N/A | N/A |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.61B | 0.13% | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.36B | 0.01% | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.55B | 0.91% | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.54B | 0.02% | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.53B | 0.67% | N/A | N/A | N/A |
Debt/Assets
32.0%
Debt/Equity
0.59
Current Ratio
2.43
Interest Coverage
1.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 32.02% |
| 2026-03-31 | 33.42% |
| 2025-12-31 | 34.37% |
| 2025-09-30 | 33.26% |
| 2025-06-30 | 33.85% |
| 2025-03-31 | 38.25% |
| 2024-12-31 | 39.05% |
| 2024-09-30 | 38.54% |
| 2024-06-30 | 39.18% |
| 2024-03-31 | 39.34% |
| 2023-12-31 | 38.93% |
| 2023-09-30 | 39.18% |
| 2023-06-30 | 38.61% |
| 2023-03-31 | 38.77% |
| 2022-12-31 | 38.41% |
| 2022-09-30 | 39.06% |
| 2022-06-30 | 38.04% |
| 2022-03-31 | 36.93% |
| 2021-12-31 | 2.40% |
| 2021-09-30 | 2.55% |
| 2021-06-30 | 2.74% |
| 2021-03-31 | 2.91% |
| 2020-12-31 | 2.99% |
| 2020-09-30 | 3.11% |
| 2020-06-30 | 11.02% |
| 2020-03-31 | 11.19% |
| 2019-12-31 | 2.14% |
| 2019-09-30 | 2.26% |
| 2019-06-30 | 2.31% |
| 2019-03-31 | 2.39% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.13% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 4.92% |
| 2017-06-30 | 5.04% |
| 2017-03-31 | 5.09% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
